Drug Trial News

RSS

Psychosocial factors and interleukin-6 among women with advanced ovarian cancer

A new study funded by the National Cancer Institute reports that social support and other behavioral factors are related to levels of a circulating protein, which at high levels is associated with a poor prognosis in advanced ovarian cancer.

13 Jun 2005

Short-term use of CPAP therapy may protect against cardiovascular disease

A common sleep therapy used to treat patients with obstructive sleep apnea (OSA) may actually have a protective effect against death related to cardiovascular disease.

13 Jun 2005

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Eli Lilly and Company today announced encouraging results from a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy").

12 Jun 2005

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.

12 Jun 2005

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

A novel compound provides long-term lowering of blood glucose levels and improves plasma lipids (fats) that are often a problem in people with type 2 diabetes -- all in a once-daily pill, according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.

12 Jun 2005

Half of 580 women diagnosed with breast cancer in one study experienced lymphedema

The good news is that there are nearly two million breast cancer survivors in the United States , and survival rates continue to increase for patients with this disease. But the flip side is that survival can present its own set of little-known complications.

12 Jun 2005

Over-the-counter painkillers more likely to cause heart attacks than banned drug Vioxx

Researchers in the UK are saying that some of the most commonly used painkillers are more likely to cause heart attacks than Vioxx, the arthritis drug withdrawn from the market last year after it was linked to heart disease.

12 Jun 2005

No need to rush to take epilepsy drugs

A new study from the UK says that it is not neccessary to rush to put people on drugs if they have only infrequent seizures.

12 Jun 2005

Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack

Patients should not stop taking the drugs involved - non-steroidal anti-inflammatory drugs (NSAIDS) - but further investigation into these treatments is needed, say the authors.

10 Jun 2005

Low birth weight - another risk factor for diabetes

Obesity, physical inactivity, genetics and age have long been recognized as risk factors for developing high blood glucose and diabetes. But over the past few years, scientists have discovered another risk - low birth weight.

10 Jun 2005

Optimists don't always fare better than pessimists in their immunologic response to stress

The difference seems to be based on the degree of stress facing the optimist and the degree to which a pessimist avoids the problem, according to an article in the current issue of the journal Brain, Behavior, and Immunity by Suzanne Segerstrom, Ph.D., of the University of Kentucky.

10 Jun 2005

Intensive therapy, even four years later, improves stroke victims speech

A new study suggests that when intensive therapy is used with people who suffered a stroke years earlier, their speaking ability seems to improve.

10 Jun 2005

Study sheds light on endometriosis pain

Women with endometriosis often have several types of chronic pain conditions because their abnormal growths develop a nerve supply that communicates with the brain, new research suggests.

10 Jun 2005

Unique therapeutic strategy to combat cachexia

Researchers at Oregon Health & Science University's Doernbecher Children's Hospital have uncovered a unique therapeutic strategy to combat cachexia - severe malnutrition and physical wasting away - in children and adults with chronic kidney disease (CKD). The study is published in the June issue of the Journal of Clinical Investigation.

9 Jun 2005

Giving individuals with single or infrequent seizures immediate treatment does not reduce their risk of seizure recurrence in the long-term

Between 1993 and 2000, David Chadwick (University of Liverpool, UK) and colleagues, recruited around 1400 patients with single or infrequent seizures from centres in the UK and around the world.

9 Jun 2005

Similarities in antiretroviral therapy efficacy in poorer countries to that in industrial nations

Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.

9 Jun 2005

Commonly used painkillers for treating inflammation may increase the risk of heart attack

Patients should not stop taking the drugs involved - non-steroidal anti-inflammatory drugs (NSAIDS) - but further investigation into these treatments is needed, say the authors.

9 Jun 2005

Molecule called Smad7 may open doors to future treatments in pancreatic and other forms of cancer

Making new strides in their ongoing effort to understand mechanisms behind the relentless growth of cancer cells, researchers at Dartmouth Medical School have found a promising key that may open doors to future treatments in pancreatic and other forms of cancer.

9 Jun 2005

Study of glial cells in the roundworm C. elegans may provide insight into a variety of human brain diseases

The key to understanding our brains may lie within a one-millimeter long worm, new research from Rockefeller University indicates. Reporting in the June issue of Developmental Cell, Shai Shaham, Ph.D., and graduate student Elliot Perens use the roundworm, C. elegans, to investigate the mysterious glial cell, which makes up 90 percent of the human brain and, when it malfunctions, can contribute to diseases like Parkinson's disease and schizophrenia.

9 Jun 2005

Healthy neighborhoods for older adults subject of study

Doctors often advise their older patients to walk more to enhance their health, but what if the sidewalks are crumbling; if they don't know a neighbor who could serve as a walking partner to help them feel safe; or if there's nothing interesting to see outside of their homes?

9 Jun 2005

Drug Trial News

Psychosocial factors and interleukin-6 among women with advanced ovarian cancer

Short-term use of CPAP therapy may protect against cardiovascular disease

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

Half of 580 women diagnosed with breast cancer in one study experienced lymphedema

Over-the-counter painkillers more likely to cause heart attacks than banned drug Vioxx

No need to rush to take epilepsy drugs

Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack

Low birth weight - another risk factor for diabetes

Optimists don't always fare better than pessimists in their immunologic response to stress

Intensive therapy, even four years later, improves stroke victims speech

Study sheds light on endometriosis pain

Unique therapeutic strategy to combat cachexia

Giving individuals with single or infrequent seizures immediate treatment does not reduce their risk of seizure recurrence in the long-term

Similarities in antiretroviral therapy efficacy in poorer countries to that in industrial nations

Commonly used painkillers for treating inflammation may increase the risk of heart attack

Molecule called Smad7 may open doors to future treatments in pancreatic and other forms of cancer

Study of glial cells in the roundworm C. elegans may provide insight into a variety of human brain diseases

Healthy neighborhoods for older adults subject of study

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News